Act 2026-561
Transparency & Verification
Verified from Official SourceAI Plain-Language Summary
Click "Generate" to create an AI-powered plain-language summary of this legislation.
Summary
Expands the types of FDA-approved epinephrine delivery systems (including needle-free options) available in schools and public organizations and provides liability protections.
Who This Bill Serves & Who's Backing It
Core Patient Populations
Patients who rely on timely access to emergency epinephrine.
Advocacy Groups Backing This Legislation
No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →
Legislative Timeline
Votes & Legislative History
Federal Stock Epinephrine Act
School Access to Emergency Epinephrine Act
Provides financial incentives for states to adopt laws requiring schools to maintain a supply of stock epinephrine auto-injectors.
Pupil health: epinephrine delivery systems
Updates California law to allow schools to stock any FDA-approved epinephrine delivery system (e.g., nasal sprays) and clarifies requirements for preschools.
Access to Emergency Medications Amendment Act of 2023
Mandates that DC public and charter schools stock undesignated epinephrine, albuterol, and glucagon, and requires staff training for administrators of medication.
While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.